ANI Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
ANI Pharmaceuticals has a total shareholder equity of $457.6M and total debt of $285.7M, which brings its debt-to-equity ratio to 62.4%. Its total assets and total liabilities are $904.4M and $446.8M respectively. ANI Pharmaceuticals's EBIT is $49.5M making its interest coverage ratio 1.8. It has cash and short-term investments of $221.1M.
Key information
62.4%
Debt to equity ratio
US$285.67m
Debt
| Interest coverage ratio | 1.8x |
| Cash | US$221.12m |
| Equity | US$457.60m |
| Total liabilities | US$446.82m |
| Total assets | US$904.42m |
Recent financial health updates
These 4 Measures Indicate That ANI Pharmaceuticals (NASDAQ:ANIP) Is Using Debt Reasonably Well
Feb 17
Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Sep 22Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Feb 22We Think ANI Pharmaceuticals (NASDAQ:ANIP) Has A Fair Chunk Of Debt
Oct 28ANI Pharmaceuticals (NASDAQ:ANIP) Is Making Moderate Use Of Debt
Apr 29Is ANI Pharmaceuticals (NASDAQ:ANIP) Using Too Much Debt?
Nov 02Recent updates
These 4 Measures Indicate That ANI Pharmaceuticals (NASDAQ:ANIP) Is Using Debt Reasonably Well
Feb 17Additional Considerations Required While Assessing ANI Pharmaceuticals' (NASDAQ:ANIP) Strong Earnings
Nov 15Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Sep 22Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Feb 22We Think ANI Pharmaceuticals (NASDAQ:ANIP) Has A Fair Chunk Of Debt
Oct 28ANI Pharma launches generic Prochlorperazine maleate tablets
Aug 29ANI Pharmaceuticals' generic dexamethasone tablets get FDA approval
Aug 16ANI Pharmaceuticals Q2 2022 Earnings Preview
Aug 05ANI Pharmaceuticals (NASDAQ:ANIP) Is Making Moderate Use Of Debt
Apr 29ANI Pharmaceuticals: Back In The Buy Zone
Feb 08Is ANI Pharmaceuticals (NASDAQ:ANIP) Using Too Much Debt?
Nov 02Financial Position Analysis
Short Term Liabilities: ANIP's short term assets ($519.8M) exceed its short term liabilities ($145.5M).
Long Term Liabilities: ANIP's short term assets ($519.8M) exceed its long term liabilities ($301.3M).
Debt to Equity History and Analysis
Debt Level: ANIP's net debt to equity ratio (14.1%) is considered satisfactory.
Reducing Debt: ANIP's debt to equity ratio has reduced from 93% to 62.4% over the past 5 years.
Debt Coverage: ANIP's debt is well covered by operating cash flow (41.6%).
Interest Coverage: ANIP's interest payments on its debt are not well covered by EBIT (1.8x coverage).